Apoptosis, also known as programmed cell death, is a fundamental process of cells including cancer cells. The signal transduction pathways of apoptosis involve many different proteins and their interactions with each other.
Protein-protein interactions involved in these apoptotic signals, like those in many other biological processes, are often determined or influenced by a short fragment of protein sequence or even certain key amino acid residues with important functional or structural roles in the protein-protein interface. For biomedical and pharmaceutical scientists, developing new molecular tools to understand and control the functions of these small protein fragments or residues and the biological and pathological processes that they mediate is a task and challenge of both fundamental interest and practical value.
In the work published in the February issue of Experimental Biology and Medicine, Huang, Zhang, Reed, An and their coworkers have developed new synthetic molecules as models to study the structural and functional role of the proline residue and tetrapeptide sequence important for the regulation of cancer cell apoptosis by the XIAP protein. The work was carried out jointly by the laboratories of Ziwei Huang and Jing An, formerly at the Sanford-Burnham Medical Research Institute in La Jolla, California and now the Cancer Research Institute and Department of Pharmacology of the State University of New York (SUNY) Upstate Medical University in Syracuse, New York, Liangren Zhang at Peking University School of Pharmaceutical Sciences in Beijing, China, and John Reed at Sanford-Burnham Medical Research Institute.
Dr. Huang, who led this international research team, stated "research on protein-protein interactions and their synthetic modulators has become a new frontier for biomedical research and pharmaceutical development. We have chosen a proline containing tetrapeptide as the model to develop new peptidomimetic molecules to study the role of proline and tetrapeptide in the binding of XIAP protein and potential inhibition of XIAP mediated protein-protein interactions critical for apoptotic signaling in cancer cells. Our results suggest that these tetrapeptide analogs can be further developed into new molecular tools to analyze the mechanisms of protein-protein interactions and signal transduction pathways of XIAP in cancer and potential leads to develop anticancer drugs. This study combined the techniques in structure-based drug design, chemistry, and cancer biology and expertise and resources at institutions in America and China. It is an example of international collaboration to apply chemistry to biology and medicine with the long term goal of finding new anticancer therapeutics".
The research team used the crystal structure of a known tetrapeptide AVPI derived from Smac protein bound to XIAP protein as the guide to design a series of peptidomimetic analogs containing a conformationally constrained proline mimetic exo-2-azabicyclo[2.2.1]heptane-3-carboxylic acid. Structural analyses using nuclear magnetic resonance (NMR) and molecular modeling showed that some of these analogs can mimic the conformations of the parent tetrapeptide. Using a fluorescence polarization assay, one of these analogs was shown to be potent like the parent tetrapeptide in binding XIAP protein. This raises the possibility that such an analog may inhibit the antiapoptotic function of XIAP (a protein inhibitor of apoptosis), thus removing the roadblock of the death signal to kill a cancer cell.
Dr. John Reed, who led the binding and biological studies of these molecules in La Jolla, California, said, "The progress made through our collaborations with Dr. Huang and colleagues is a component of a substantial commitment we have made at Sanford-Burnham to discovery and design of small molecule chemical inhibitors of IAP family proteins as potential therapeutics for cancer. We are eager to advance the work towards drug-like leads that might provide renewed hope for those suffering from advanced malignancies."
The design and synthesis of the peptide analogs described in the study are the beginning steps in the long process of research and development of suitable pharmaceutical agents capable of penetrating a cancer cell membrane to reach the XIAP target and triggering the signaling pathway that causes the death of cancer cells in vivo. While further modifications and studies are needed on these peptide analogs in order to show their practical values as cell permeable anticancer agents, the present study of these analogs is of basic research interest for understanding the role of proline and conformation of prolyl peptide bond in mediating the biological function of a protein. It is known that the two different conformational isomers (cis and trans isomers) of the prolyl peptide bond can mediate distinct function of the protein. Many studies in the past of proline and proline mimics show either a mixture of cis and trans isomers or purely cis isomer. In this study, the proline mimic displayed strictly the trans conformation. The interesting conformational and functional effects of the synthetic unnatural mimic of proline discovered here suggest an alternative probe of prolyl isomerization in biology and that such a proline mimic can be applied to study the role of proline and proline containing sequence in other protein-protein interactions involved in a wide range of biological functions.
Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine, said "This elegant study by Ziwei Huang and colleagues explores the role of proline containing peptides in inhibiting the anti-apoptotic function of XIAP. This will potentially lead the way to new designer anti-cancer drugs. The article is a wonderful example of the interdisciplinary and international research that is the focus of our journal".
Experimental Biology and Medicine is a journal dedicated to the publication of multidisciplinary and interdisciplinary research in the biomedical sciences. The journal was first established in 1903.
Experimental Biology and Medicine is the journal of the Society of Experimental Biology and Medicine. To learn about the benefits of society membership visit www.sebm.org. If you are interested in publishing in the journal please visit http://ebm.rsmjournals.com.
Dr. Ziwei Huang | EurekAlert!
Further reports about: > Experimental Biology > Medicine > anti-cancer drug > apoptotic function > biological function > biological process > cancer cells > cancer drug > international research > molecular tool > protein-protein interactions > signal transduction > synthetic biology > transduction pathway
Nanoparticle Exposure Can Awaken Dormant Viruses in the Lungs
16.01.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Cholera bacteria infect more effectively with a simple twist of shape
13.01.2017 | Princeton University
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.
The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...
10.01.2017 | Event News
09.01.2017 | Event News
05.01.2017 | Event News
17.01.2017 | Earth Sciences
17.01.2017 | Materials Sciences
17.01.2017 | Architecture and Construction